Biotechnology breakthrough could revolutionize treatment for neurodegenerative diseases
A research team from the School of Biomedical Sciences at the LKS Faculty of Medicine, the University of Hong Kong (HKUMed), has achieved a significant breakthrough in biotechnology that could revolutionize treatment strategies for neurodegenerative diseases.
news-medical.net/news/20260612/Biotechnology-breakthrough-could-revolutionize-treatment-for-neurodegenerative-diseases.aspx
---
@Genica_NEWS
Researchers discover 45 new toxins produced by Salmonella bacteria
Researchers at the University of São Paulo (USP) in Brazil have discovered 45 new toxins produced by Salmonella bacteria, some of which are associated with foodborne infections.
news-medical.net/news/20260611/Researchers-discover-45-new-toxins-produced-by-Salmonella-bacteria.aspx
---
@Genica_NEWS
New hybrid lens design drastically cuts 3D microscopy costs and complexity
A team led by Raju Tomer, professor of biological sciences at Columbia University, has created a new design for microscopes and microscope lenses that could push 3D tissue imaging beyond state-of-the-art systems while drastically cutting costs and complexity.
news-medical.net/news/20260610/New-hybrid-lens-design-drastically-cuts-3D-microscopy-costs-and-complexity.aspx
---
@Genica_NEWS
Laverock Therapeutics reports key oncology research milestones
Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced key in-vivo functional milestones across its T-cell and macrophage oncology programs for solid tumor indications.
news-medical.net/news/20260610/Laverock-Therapeutics-reports-key-oncology-research-milestones.aspx
---
@Genica_NEWS
New geroscience initiative aims to accelerate anti‑aging therapies
Albert Einstein College of Medicine has launched the Batia and Idan Ofer program for Validation of Interventions Targeting Aging and Longevity (BIO-VITAL), a new initiative designed to help biotechnology and pharmaceutical companies advance therapies that target the biology of aging.
news-medical.net/news/20260609/New-geroscience-initiative-aims-to-accelerate-antie28091aging-therapies.aspx
---
@Genica_NEWS
How Programmable Nanobiology Could Drive the Fifth Industrial Revolution
Professor Heddle's insights on nanobiology and AI highlight their potential to innovate drug delivery and vaccine development, addressing critical health needs.
news-medical.net/news/20260609/How-Programmable-Nanobiology-Could-Drive-the-Fifth-Industrial-Revolution.aspx
---
@Genica_NEWS
New non-invasive tool lowers cancer DNA tracking threshold to 5%
Blood tests have proved to be a promising tool for detecting and monitoring cancer. Researchers at Chalmers University of Technology and the University of Gothenburg, Sweden, have now developed a new method that makes it possible to analyze samples containing as little as 5 per cent cancer DNA in the blood, compared with the 15–20 per cent required today. This method could lead to better cancer care and improved monitoring of tumor progression.
news-medical.net/news/20260609/New-non-invasive-tool-lowers-cancer-DNA-tracking-threshold-to-525.aspx
---
@Genica_NEWS
Expert review examines widely-held beliefs about dietary protein needs and benefits
A newly published peer-reviewed paper in Critical Reviews in Food Science and Nutrition synthesizes findings from a February 2025 scientific workshop.
news-medical.net/news/20260608/Expert-review-examines-widely-held-beliefs-about-dietary-protein-needs-and-benefits.aspx
---
@Genica_NEWS
Researchers challenge the traditional understanding of how histone deacetylase inhibitors function
Researchers at Baylor College of Medicine and collaborating institutions are challenging the traditional understanding of how cancer drugs called histone deacetylase (HDAC) inhibitors function.
news-medical.net/news/20260605/Researchers-challenge-the-traditional-understanding-of-how-histone-deacetylase-inhibitors-function.aspx
---
@Genica_NEWS
Study shows how TAF1 regulates ferroptosis in cancer cells
Ferroptosis has become a promising area in cancer research because it may provide a way to target tumor cells that evade other better-known forms of programmed cell death, such as apoptosis and necroptosis.
news-medical.net/news/20260603/Study-shows-how-TAF1-regulates-ferroptosis-in-cancer-cells.aspx
---
@Genica_NEWS
Gladstone receives NIAID grant to establish the Center for PhAIge Therapy
When a bacterial infection stops responding to antibiotics, doctors have few options to treat it. Phages-viruses that naturally infect and kill bacteria-have long intrigued clinicians as a potential weapon against these infections.
news-medical.net/news/20260602/Gladstone-Institutes-receives-NIAID-grant-to-establish-the-Center-for-PhAIge-Therapy.aspx
---
@Genica_NEWS
E-cigarette flavors and device type drive the biological effects of vaping
People who vape regularly show altered activity in 3,124 genes across the genome compared with people who do not smoke or vape.
news-medical.net/news/20260601/E-cigarette-flavors-and-device-type-drive-the-biological-effects-of-vaping.aspx
---
@Genica_NEWS
Laverock Therapeutics awarded in excess of £2.2 M through two innovation grants to support AI-powered platform development and to expand therapeutic programs outside of oncology
Laverock Therapeutics ('Laverock'), a biotechnology company developing disease-responsive advanced therapies through its unique, programmable gene control technology, today announced it has been awarded two new grants totaling in excess of £2.2 M to support the next generation of its gene-control platform development, and expansion into additional non-oncology therapeutics areas.
news-medical.net/news/20260601/Laverock-Therapeutics-awarded-in-excess-of-c2a322-M-through-two-innovation-grants-to-support-AI-powered-platform-development-and-to-expand-therapeutic-programs-outside-of-oncology.aspx
---
@Genica_NEWS
The growing role of NIR-II imaging in preclinical research
NIR-II imaging has many advantages for preclinincal research as it supports deeper visualization with lower scattering and autofluorescence.
news-medical.net/news/20260529/The-growing-role-of-NIR-II-imaging-in-preclinical-research.aspx
---
@Genica_NEWS
Gut microbiota may determine severity of life-threatening sepsis infections
Why do some people recover easily from bacterial infections while others rapidly deteriorate into life-threatening sepsis? According to a new study, the answer may lie not only in the invading pathogen itself, but also in the microorganisms already living inside the gut.
news-medical.net/news/20260528/Gut-microbiota-may-determine-severity-of-life-threatening-sepsis-infections.aspx
---
@Genica_NEWS
Metformin reduces long COVID risk according to ACTIV-6 clinical trial
New findings from the ACTIV-6 randomized clinical trial provide important confirmation of prior clinical trial results that metformin, a widely available and inexpensive medication with an established safety record, reduced the risk of clinician-diagnosed long COVID when started during acute COVID-19 infection.
news-medical.net/news/20260611/Metformin-reduces-long-COVID-risk-according-to-ACTIV-6-clinical-trial.aspx
---
@Genica_NEWS
Short four-minute workout boosts quality of life for seniors
Just four minutes of daily strengthening exercise dramatically increases key factors in quality of life for aging adults, according to a new study led by researchers at Penn State College of Medicine.
news-medical.net/news/20260610/Four-minutes-of-daily-workout-boosts-quality-of-life-for-seniors.aspx
---
@Genica_NEWS
Critical Path Institute opens registration for 2026 Global Impact Conference
Critical Path Institute (C-Path) will host its 2026 Global Impact Conference (CGIC) this September at the Washington Marriott at Metro Center in Washington, D.C.
news-medical.net/news/20260610/Critical-Path-Institute-opens-registration-for-2026-Global-Impact-Conference.aspx
---
@Genica_NEWS
Study identifies key protein driving colon cancer drug resistance
One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.
news-medical.net/news/20260609/Study-identifies-key-protein-driving-colon-cancer-drug-resistance.aspx
---
@Genica_NEWS
Study identifies key protein driving colon cancer drug resistance
One of the most widely used chemotherapeutic agents for colorectal cancer is 5-fluorouracil (5-FU), a cornerstone treatment that has improved outcomes for countless patients.
news-medical.net/news/20260609/Study-identifies-key-protein-driving-colon-cancer-drug-resistance.aspx
---
@Genica_NEWS
How Programmable Nanobiology Could Drive the Fifth Industrial Revolution
Professor Heddle's insights on nanobiology and AI highlight their potential to innovate drug delivery and vaccine development, addressing critical health needs.
news-medical.net/news/20260609/How-Programmable-Nanobiology-Could-Drive-the-Fifth-Industrial-Revolution.aspx
---
@Genica_NEWS
Blocking immune pathway slows Huntington disease in mouse models
Huntington disease is a rare, inherited brain disorder that progressively destroys nerve cells, leading to worsening movement, cognitive and psychiatric symptoms.
news-medical.net/news/20260608/Blocking-immune-pathway-slows-Huntington-disease-in-mouse-models.aspx
---
@Genica_NEWS
Infant receives world's first gene therapy for WOREE syndrome
An eight-month-old infant with a severe genetic epilepsy has become the first patient in the world to receive an experimental gene replacement therapy designed to restore the function of the WWOX gene directly in the brain.
news-medical.net/news/20260608/Infant-receives-worlds-first-gene-therapy-for-WOREE-syndrome.aspx
---
@Genica_NEWS
Light-activated proteins demonstrate quantum sensing and radio wave control
Until now, quantum sensing has primarily been known from solid-state materials such as diamonds with deliberately introduced tiny defects.
news-medical.net/news/20260603/Light-activated-proteins-demonstrate-quantum-sensing-and-radio-wave-control.aspx
---
@Genica_NEWS
New platform identifies barriers to therapeutic antibody delivery in solid tumors
Eben Rosenthal, MD, the Barry and Amy Baker Professor and Chair of the Department of Otolaryngology-Head and Neck Surgery at Vanderbilt Health, is the senior author of the paper. Rosenthal and co-author Guolan Lu, PhD, of Stanford University School of Medicine, developed single-cell spatial pharmacobiology (SSP), an experimental and analytical platform that allows visualization of drug-tumor interactions in human solid tumors.
news-medical.net/news/20260603/New-platform-identifies-barriers-to-therapeutic-antibody-delivery-in-solid-tumors.aspx
---
@Genica_NEWS
Advancing Human Muscle Models for Drug Development and Preclinical Testing
Transforming drug development, Myomaker Bio's lab-grown muscle platforms offer human-relevant models for effective preclinical testing and risk reduction.
news-medical.net/news/20260602/Advancing-Human-Muscle-Models-for-Drug-Development-and-Preclinical-Testing.aspx
---
@Genica_NEWS
New SMArT platform improves safety of CRISPR gene editing
A team of researchers led by Luigi Naldini at the San Raffaele Telethon Institute for Gene Therapy (SR-Tiget) has developed a new strategy to significantly improve the precision and safety of CRISPR-Cas9 gene editing in human blood stem cells, potentially overcoming one of the major barriers limiting broader clinical application of genome editing therapies.
news-medical.net/news/20260601/New-SMArT-platform-improves-safety-of-CRISPR-gene-editing.aspx
---
@Genica_NEWS
Grant funds research into molecular memories behind exaggerated fear
Experiencing a traumatic event sometimes produces long-lasting biological changes that can lead to an exaggerated fear response to future stressful events, such as what occurs in individuals with post-traumatic stress disorder (PTSD).
news-medical.net/news/20260529/Grant-funds-research-into-molecular-memories-behind-exaggerated-fear.aspx
---
@Genica_NEWS
Brain transposons may influence aging and neurodegenerative disease progression
Transposable elements (TEs), also called transposons, are DNA sequences capable of moving or replicating from one location to another within a genome.
news-medical.net/news/20260528/Brain-transposons-may-influence-aging-and-neurodegenerative-disease-progression.aspx
---
@Genica_NEWS
Gut microbiota may determine severity of life-threatening sepsis infections
Why do some people recover easily from bacterial infections while others rapidly deteriorate into life-threatening sepsis? According to a new study, the answer may lie not only in the invading pathogen itself, but also in the microorganisms already living inside the gut.
news-medical.net/news/20260528/Gut-microbiota-may-determine-severity-of-life-threatening-sepsis-infections.aspx
---
@Genica_NEWS
